Opioid regimens in patients with chronic pain with multiple cytochrome P450 defects
1Veract Intractable Pain Clinic, West Covina, California.
Abstract:
There is a subgroup of patients with chronic pain who have multiple cytochrome P450 enzyme defects. These patients tend to use opioids that are not metabolized by the CYP450 system and most apparently require a higher than average dosage. A significant number require nonoral administration.
More Related Videos
09:38Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Opioid Receptors: Overview
Dosage Regimens: Partial Pharmacokinetic Parameters
